2Muller I,Besta F,Sehulz C,et al.Prevalence of elopidogrel nonresponders among patients with stable angina pectoris scheduled for elective coronary stent placement[J].Thromb Haemost,2003,89:783-787.
3Nguyen TA,Diodati JG,Pharand C.Resistance to clopidogrel a review of the evidence[J].Circulation,2004,20,109(2):66-71.
4Guthikonda S,Lev EI,Klieiman NS.Resistance to antiplatelet therapy[J].Curr Cardiol Rep,2005,7(4):242-248.
5Matetzky S,Shenkllman B,Guetta V,et al.Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction[J].Cireulation,2004,109:3171-3175.
6Nguyen TA,Diodati JG,Pharand C.Resistance to clopi2dogrel:a review of t he evidence[J].J Am Coll Cardiol,2005,45(8):1157-1164.
7Paul A,Gurbel MD.Clopidogrel for coronary stenting:response varisbility,drug resistance,and the effect of pretreatment platel-et[J].Circulation,2003,107:2908-2913.
8Roccb B,Patrono.C Determinants of the interindividual variability in the response to antiplatelet drugs[J].J Thromb Haemost,2005,(3):1597-1602.
9Lev El,Patel RT,Maresh KJ.Aspirin and clopidogreldrug response in patients undergoing percutaneous coronary intervention:the role of dual drug resistanee[J].J Am Coll Cardiol,2006,47:27-33.
10Wenaweser P,Dorffler-Melly J,Imboden K.Stent thrombosis is assoeiated with an impaired response to antiplatelet therapy[J].J Thromb Haemost,2005,45:1748-1752.
